Back to search

National and Kapodistrian University of Athens

Η έκφραση και ενεργοποίηση του PRARy, ως το προ-αποπτωτικό σύστημα μεταγωγής σήματος της δοξορουμπικίνης, στα κύτταρα καρκίνου προστάτη ( PC-3 cells) in vitro και στο τρισδιάστατο σύστημα καλλιέργειας κολλαγόνου τύπου Ι ( 3-D collagen system), παρουσία ή απουσία συν-καλλιέργειας οστεοβλαστών

Abstract

dc:description

PPAR-γ a member of the peroxisome proliferator-activated receptor family is overexpressed in tumors and several prostate cancer cell lines. In vitro and in vivo studies in cancers have implicated PPARγ ligands as inhibitors of cell growth and promoters of cell cycle arrest, apoptosis and/or differentiation in prostate cancer cell lines such as in PC-3 cell line. These ligands exert their anticancer effect via both “genomic” as well as “non-genomic” events. The non-genomic action of PPARγ ligands, including the activation of MAPK and PI3-K signaling pathways, is presently under intense investigation. However a crucial issue in patients with advanced prostate cancer is that osteoblastic metastases are hormone-independent and cytotoxic drug resistant. Therefore, we analyzed the ability of two PPAR-γ ligands 15dPGJ2 and rosiglitazone, a natural and a synthetic ligand of PPAR-γ respectively, to increase adriamycin effectiveness on cytotoxicity and to decrease the survival factor effect of osteoblast-related growth factor IGF-1 on adriamycin-induced apoptosis of PC-3 prostate cancer cells. Our studies revealed that the two ligands have opposing effects upon IGF-1 ability to develop cytotoxic drug resistance through early non-genomic effects, and especially through the IGF-1R signaling pathways which involve ERK1/2 and Akt. Since the IGF1.R signaling is probably the most important host tissue (bone) metastasis microenvironment-related survival signaling for prostate cancer cells, we conclude that PPARγ ligand effects on IGF1.R-mediated activation of ERK1/2 and AKT could have clinical implications for the management of androgen ablation-refractory and chemotherapy-resistant advanced prostate cancer with bone metastasis

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papageorgiou, Efstathia
  • Παπαγεωργίου, Ευσταθία

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/18339

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papageorgiou, Efstathia; Παπαγεωργίου, Ευσταθία. Η έκφραση και ενεργοποίηση του PRARy, ως το προ-αποπτωτικό σύστημα μεταγωγής σήματος της δοξορουμπικίνης, στα κύτταρα καρκίνου προστάτη ( PC-3 cells) in vitro και στο τρισδιάστατο σύστημα καλλιέργειας κολλαγόνου τύπου Ι ( 3-D collagen system), παρουσία ή απουσία συν-καλλιέργειας οστεοβλαστών. National and Kapodistrian University of Athens, 2008. http://hdl.handle.net/10442/hedi/18339